Roman Bradel

Roman Bradel serves as the Vice President of Regulatory Affairs at Supernus Pharmaceuticals, Inc., starting in March 2024. Prior to this role, Roman operated as an Independent Consultant from February 2023 to December 2023, providing regulatory support for pharmaceutical and medical device companies. Roman also held the position of Senior Director of Regulatory Affairs at ORYN THERAPEUTICS, Inc., from March 2022 to January 2023, where responsibilities included devising regulatory strategies for early-stage clinical development. Earlier, as Senior Director of Regulatory Affairs at Prolacta Bioscience from August 2016 to March 2022, Roman led the development of drug products derived from human milk. Roman's experience also encompasses roles at NewLink Genetics and AbbVie, contributing significantly to regulatory submissions for various oncology therapies and supporting the world’s largest commercial biologic product, HUMIRA®. Roman's academic credentials include a Ph.D. in Medicinal and Pharmaceutical Chemistry from Technische Universität Berlin.